Connect with us

Life Sciences

Save the date for the 11th World Congress on Targeting Microbiota 2024 – Revolutionizing Future Medicine

Targeting Microbiota 2024: Vision, Strategies and Perspectives Credit: International Society of Microbiota Targeting Microbiota 2024: Vision, Strategies…

Published

on

This article was originally published by BioEngineering

Targeting Microbiota 2024: Vision, Strategies and Perspectives

Targeting Microbiota 2024

Credit: International Society of Microbiota

Targeting Microbiota 2024: Vision, Strategies and Perspectives

The 11th Annual Congress of the International Society of Microbiota (ISM), Targeting Microbiota 2024, is scheduled on October 17-18, at Corinthia Palace Malta. Targeting Microbiota 2024 will not only present the latest advancements but also serve as a pivotal hub for sharing visionary strategies and perspectives that will redefine the landscape of medicine. The Congress promises an immersive experience, offering a dynamic platform for the exchange of ideas, insights, and the exploration of innovative approaches that will shape the future of medicine.

Save the date and join the ISM community in exploring the vast potential of microbiota and how it’s set to revolutionize healthcare and wellness.

 

A look back on Targeting Microbiota 2023

Last year’s congress on Targeting Microbiota, a pioneering event in Venice and online from October 17-19, marked a significant milestone in microbiota research. Hosted on the picturesque Isola di San Servolo, it united over 278 experts from 27 countries, offering pioneering insights into microbiota’s diverse roles. With thought-provoking discussions and 72 impactful presentations, the event delved into the influence of microbiota on health, disease, and the environment. The intersection of industry and academia highlighted groundbreaking technologies.

 

Outstanding Achievements Awarded at Targeting Microbiota 2023:

  • Best Scientific Contribution Award: Prof. Lena Öhman, University of Gothenburg, Sweden, for her outstanding research on “Fecal Gut Microbiota and Metabolite Signatures as Biomarkers for Gastrointestinal Disorders”.
  • Best Short Oral Presentation Award: Francesca Damiani, Scuola Normale Superiore, Italy for her contribution on “Microbiota Manipulation as a Potential Therapeutic Strategy to Improve Clinical Symptoms in CDKL5 Deficiency Disorder”.
  • Best Poster Presentation Award: Kelly Conde Pérez, The Universitary Hospital of A Coruña, Spain, for her presentation “Parvimonas Micra Translocates From Subgingival Pockets to Tumors in Colorectal Cancer Patients”.

 

Post-Congress 2023 Materials Available

The International Society of Microbiota offers you access to insightful replays and reading materials.

Conference Replay Access: Engage with over 42 notable oral sessions and talks in Conference Videos.

Book of Abstracts: Explore a comprehensive digital booklet containing all 63+ abstracts in Abstracts Compilation.

Access the replay and reading materials.

 

Join us in Malta and immerse yourself in the forefront of microbiota research!

Stay updated on Targeting Microbiota 2024 on our website: www.microbiota-site.com.

 

The International Society of Microbiota extends its best wishes for this season. Wishing you a joyful holiday and a prosperous New Year with your loved ones.



wellness

Life Sciences

Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Markets

Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….

Continue Reading

Trending